Evidence map›Paper›PMID 33108640›Full record

Observational studyInternal and emergency medicine2021

Safety and effectiveness of biosimilar enoxaparin (Inhixa) for the prevention of thromboembolism in medical and surgical inpatients.

Chiara Fantoni, Lorenza Bertù, Elena Maria Faioni, Caterina Froiio, Nicolò Mariani, Walter Ageno

Open access · greenAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Chiara FantoniDepartment of Medicine, Maggiore Hospital, Bologna, Italy. c.fantoni@hotmail.it.ORCID http://orcid.org/0000-0002-5529-8698
Lorenza BertùDepartment of Medicine and Surgery, University of Insubria, Varese, Italy.
Elena Maria FaioniDepartment of Health Sciences, University of Milan, Milan, Italy.
Caterina FroiioUniversity of Milan, Milan, Italy.
Nicolò MarianiASST Santi Paolo E Carlo, Milan, Italy.
Walter AgenoDepartment of Medicine and Surgery, University of Insubria, Varese, Italy.
University of Insubria · ITUniversity of Milan · ITAzienda Socio Sanitaria Territoriale Santi Paolo e CarloOspedale Maggiore Carlo Alberto Pizzardi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016, biosimilar enoxaparin (Inhixa

Indexed as

InpatientsAgedAnticoagulantsBiosimilar PharmaceuticalsEnoxaparinFemaleHumansItalyMaleRetrospective StudiesVenous ThromboembolismAnticoagulantsBiosimilar PharmaceuticalsEnoxaparinBiosimilarEnoxaparinInhixaLMWHPrevention

Identifiers

PMID33108640
OpenAlexW3097915085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.